These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 32710727)
1. Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling. Shi L; Sun G; Zhu H Aging (Albany NY); 2020 Jul; 12(14):14718-14735. PubMed ID: 32710727 [TBL] [Abstract][Full Text] [Related]
2. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas. Shi L; Sun G; Zhang Y Aging (Albany NY); 2020 Nov; 12(23):23795-23807. PubMed ID: 33221748 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells. Yang L; Guo H; Dong L; Wang L; Liu C; Wang X Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314 [TBL] [Abstract][Full Text] [Related]
4. Ampelopsin inhibits human glioma through inducing apoptosis and autophagy dependent on ROS generation and JNK pathway. Guo Z; Guozhang H; Wang H; Li Z; Liu N Biomed Pharmacother; 2019 Aug; 116():108524. PubMed ID: 31108349 [TBL] [Abstract][Full Text] [Related]
5. DMC is not better than TMZ on intracranial anti-glioma effects. Shi L; Sun G J Cell Biochem; 2018 Jul; 119(7):6057-6064. PubMed ID: 29575236 [TBL] [Abstract][Full Text] [Related]
6. ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin. Chen L; Shi L; Wang W; Zhou Y Oncotarget; 2017 Jun; 8(26):43237-43247. PubMed ID: 28591733 [TBL] [Abstract][Full Text] [Related]
7. Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice Huang YP; Ma YS; Kuo CL; Liao CL; Chen PY; Peng SF; Hsu FT; Lai KC Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071132 [TBL] [Abstract][Full Text] [Related]
8. Dihydroartemisinin exhibits anti-glioma stem cell activity through inhibiting p-AKT and activating caspase-3. Cao L; Duanmu W; Yin Y; Zhou Z; Ge H; Chen T; Tan L; Yu A; Hu R; Fei L; Feng H Pharmazie; 2014 Oct; 69(10):752-8. PubMed ID: 25985565 [TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
10. Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway. Wen N; Guo B; Zheng H; Xu L; Liang H; Wang Q; Wang D; Chen X; Zhang S; Li Y; Zhang L Int J Oncol; 2019 Oct; 55(4):879-895. PubMed ID: 31485609 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA 145 enhances chemosensitivity of glioblastoma stem cells to demethoxycurcumin. Qian C; Wang B; Zou Y; Zhang Y; Hu X; Sun W; Xiao H; Liu H; Shi L Cancer Manag Res; 2019; 11():6829-6840. PubMed ID: 31440081 [No Abstract] [Full Text] [Related]
12. Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner. Gu C; Banasavadi-Siddegowda YK; Joshi K; Nakamura Y; Kurt H; Gupta S; Nakano I Stem Cells; 2013 May; 31(5):870-81. PubMed ID: 23339114 [TBL] [Abstract][Full Text] [Related]
13. Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells. Shi L; Fei X; Wang Z Tumour Biol; 2015 Sep; 36(9):7107-19. PubMed ID: 25877753 [TBL] [Abstract][Full Text] [Related]
14. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma. Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821 [TBL] [Abstract][Full Text] [Related]
15. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs). Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567 [TBL] [Abstract][Full Text] [Related]
17. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells. Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970 [TBL] [Abstract][Full Text] [Related]
18. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo. Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379 [TBL] [Abstract][Full Text] [Related]
19. Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma. Wang Y; Huang N; Li H; Liu S; Chen X; Yu S; Wu N; Bian XW; Shen HY; Li C; Xiao L Oncotarget; 2017 Jun; 8(23):37511-37524. PubMed ID: 28415586 [TBL] [Abstract][Full Text] [Related]
20. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells. Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]